• Latest Posts

Five companies racing to bring their NASH treatments toward the finish line

In Depth 19 Oct 2023

Biotech’s battle against NASH: The ongoing pursuit of an effective treatment

Five latest advancements in NASH research

First drug discovered through 3D bioprinted tissue disease model

More News! 4 Nov 2022

Alimentiv and Summit collaborate to tackle liver disease NASH

More News! 16 Sep 2022

Strategic collaboration for drug to treat NASH, obesity and diabetes announced


Poxel publishes ALD studies

Genfit’s Phase III Drug Fails to Treat NASH, But New Players On Horizon

Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial

Genfit’s NASH Drug to Be Developed in China in Deal Worth up to €200M